Delivery Order SPE2DB20D1109-SPE2DB25FP22R
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under contract SPE2DX15D1053|SPE2DX25F6NKS, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,852.98 firm-fixed-price contract is for the delivery of 4,568,202,798 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The award is not set aside and has a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a $16,413.14 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a completion date of June 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,604.17 contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,472.74, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The delivery order has a firm fixed price and an ultimate completion date of April 11, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,005.10 contract is for the supply of 4,568,093,505 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a $1,611.96 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a performance period through June 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a comprehensive global pharmaceutical support...
This is a $5,976.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a period of performance through June 17, 2025. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a $5,405.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is a $6,483.00 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a period of performance through June 13, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a $1,555.92 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of June 16, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...